Anti-D immunoglobulin in RhD prophylaxis.
Robson
S C
SC
Department of Obstetrics and Gynaecology, University of Newcastle upon Tyne.
Lee
D
D
Urbaniak
S
S
D000033:Abortion, Threatened; D003245:Consensus Statements as Topic; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008428:Maternal Mortality; D011181:Postnatal Care / Q000191:economics / Q000379:methods; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011295:Prenatal Care / Q000191:economics / Q000379:methods; D011644:Puerperal Disorders / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012203:Rh Isoimmunization / Q000191:economics / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage / Q000627:therapeutic use*; D014592:Uterine Hemorrhage / Q000517:prevention & control
D018029:Rho(D) Immune Globulin